Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Real-World Registry of Characteristics, Treatment Strategies, and Clinical Outcomes in Chinese Adults With Chronic Kidney Disease

NCT07481526 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07481526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07481526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Real-World Registry of Characteristics, Treatment Strategies, and Clinical Outcomes in Chinese Adults With Chronic Kidney Disease
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2026
Completion date
December 30, 2028
Enrollment
3,000 (estimated)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease